Critical role of Vα14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection

European Journal of Immunology

Volumn 33, Issue 12, 2003, Pages 3322-3330

  Kawakami, Kazuyoshi ^a   Yamamoto, Natsuo ^a   Kinjo, Yuki ^a   Miyagi, Kazuya ^a   Nakasone, Chikara ^a   Uezu, Kaori ^a   Kinjo, Takeshi ^a   Nakayama, Toshinori ^b   Taniguchi, Masaru ^b,c   Saito, Atsushi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c RIKEN   (Japan)

Author keywords

Host defense; Monocyte chemotactic protein 1; Neutrophils; NKT cells; Streptococcus pneumoniae

Indexed keywords

CD1D ANTIGEN; GALACTOSYLCERAMIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; TETRAMER; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; CELL TRANSPORT; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; GENE DISRUPTION; HOST RESISTANCE; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MOUSE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; STREPTOCOCCUS PNEUMONIA; SURVIVAL TIME; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; WILD TYPE;

EID: 0346752118     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324254     Document Type: Article

References (55)

1. Gant, V. and Parton, S., Community-acquired pneumonia. Curr. Opin. Pulm. Med. 2000. 6: 226-233.
2. Marrie, T. J., Pneumococcal pneumonia: epidemiology and clinical features. Semin. Respir. Infect 1999. 14: 227-236.
3. Cunha, B. A., Clinical relevance of penicillin-resistant Streptococcus pneumoniae. Semin. Respir. Infect. 2002. 17: 204-214.
4. Musher D., Cohen, M. and Baker, C., Immune responses to extracellular bacteria. In Rich, R. R., Fleisher, T. A., Schwartz, B. D., Shearer, W. T. and Strober, W. (Eds.) Clinical immunology. Principles and Practice. Mosby-Year Book, St. Louis 1996, pp 479-502.
5. Tsai, W. C., Strieter, R. M., Mehard, B., Newstead, M. W., Zeng, X. and Standiford, T. J., CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect. Immun. 2000. 68: 4289-4296.
6. Greenberger, M. J., Strieter, R. M., Kunkel, S. L., Danforth, J. M., Laichalk, L. L., McGillicuddy, D. C. and Standiford, T. J., Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J. Infect. Dis. 1996. 173: 159-165.
7. Standiford, T. J., Kunkel, S. L., Greenberger, M. J., Laichalk, L. L. and Strieter, R. M., Expression and regulation of chemokines in bacterial pneumonia. J. Leukoc. Biol. 1996. 59: 24-28.
8. Chen, S. C., Mehrad, B., Deng, J. C., Vassileva, G., Manfra, D. J., Cook, D. N., Wiekowski, M. T., Zlotonik, A., Standiford, T. J. and Lira, S. A., Impaired pulmonary host defense in mice lacking expression of the CXC chemokine lungkine. J. Immunol. 2001. 166: 3362-3368.
9. Takashima, K., Tateda, K., Matsumoto, T., Iizawa, Y., Nakano, M. and Yamaguchi, K., Role of tumor necrosis factor-α in pathogenesis of pneumococcal pneumonia in mice. Infect. Immun. 1997. 65: 257-260.
10. van der Poll, T., Keogh, C. V., Buurman, W. A. and Lowry, S. F., Passive immunization against tumor necrosis factor-α impairs host defense during pneumococcal pneumonia in mice. Am. J. Respir Crit. Care Med. 1997. 155: 603-608.
11. Laichalk, L. L., Kunkel, S. L., Strieter, R. M., Danforth, J. M., Bailie, M. B. and Standiford, T. J., Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect. Immun. 1996. 64: 5211-5218.
12. Rijneveld, A. W., Florquin, S., Branger, J., Speelman, P., van Deventer, S. J. and van der Poll, T., TNF-α compensates for the impaired host defense of IL-1 receptor-deficient mice during pneumococcal pneumonia. J. Immunol. 2001. 167: 5240-5246.
13. van der Poll, T., Keogh, C. V., Guirao, X., Buurman, W. A., Kopf, M. and Lowry, S. F., Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J. Infect. Dis. 1997. 176: 439-444.
14. Moore, T. A., Moore, B. B., Newstead, M. W. and Standiford, T. J., γδ-T cells are critical for survival and early proinflammatory cytokine gene expression during murine Klebsiella pneumonia. J. Immunol. 2000. 165: 2643-2650.
15. Khater, M., Macai, J., Genyea, C. and Kaplan, J., Natural killer cell regulation of age-related and type-specific variations in antibody responses to pneumococcal polysaccharides. J. Exp. Med. 1986. 164: 1505-1515.
16. Taniguchi, M. and Nakayama, T., Recognition and function of Vα14 NKT cells. Semin. Immunol. 2000. 12: 543-550.
17. Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J. and Baxter, A. G., NKT cells: facts, functions and fallacies. Immunol. Today 2000. 21: 573-583.
18. Kronenberg, M. and Gapin, L., The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2002. 2: 557-568.
19. Kawano, T., Cui, J., Koezuka, Y., Tours, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., Koseki, H. and Taniguchi, M., CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 1997. 278: 1626-1629.
20. Behar, S. M., Dascher, C. C., Grusby, M. J., Wang, C.-R. and Brenner, M. B., Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. Med. 1999. 189: 1973-1980.
21. Sousa, A. O., Mazzaccaro, R. J., Russell, R. G., Lee, F. K., Turner, O. C., Hong, S., van Kaer, L. and Bloom, B. R., Relative contribution of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc. Natl. Acad. Sci. USA 2000. 97: 4204-4208.
22. Kawakami, K., Kinjo, Y., Uezu, K., Yara, S., Miyagi, K., Koguchi, Y., Nakayama, T., Taniguchi, M. and Saito, A., Minimal contribution of Vα14 natural killer T cells to Th1 response and host resistance against mycobacterial infection in mice. Microbiol. Immunol. 2002.46: 207-210.
23. + T cells for liver injury induced by Salmonella infection in mice. Hepatology 1999. 29: 1799-1808.
24. Chackerian, A., Alt, J., Perera, V., Behar, S. M., Activation of NKT cells protects mice from tuberculosis. Infect. Immun. 2002. 70: 6302-6309.
25. Szalay, G., Ladel, C. H., Blum, C., Brossay, L., Kronenberg, M. and Kaufmann, S. H. E., Anti-CD1 monoclonal antibody treatment reverses the production patterns of TGF-β2 and Th1 cytokines and ameliorates listeriosis in mice. J. Immunol. 1999. 162: 6955-69558.
26. Nakano, Y., Hisaeda, H., Sakai, T., Zhang, T., Maekawa, M. and Himeno, K., Role of innate immune cells in protection against Toxoplasma gondii at inflamed site. J. Med. Invest. 2001. 48: 73-80.
27. Ishikawa, H., Hisaeda, H., Taniguchi, M., Nakayama, T., Sakai, T., Maekawa, Y., Nakano, Y., Zhang, M., Nishitani, M., Takashims, M. and Himeno, K., CD4+ Vα14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int. Immunol. 2000. 12: 1267-1274.
28. Kawakami, K., Kinjo, Y., Uezu, K., Yara, S., Miyagi, K., Koguchi, Y., Nakayama, T., Taniguchi, M. and Saito, A., Monocyte chemoattractant protein-1-dependent increase of Vα14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J. Immunol. 2001. 167: 6525-6532.
29. Nieuwenhuis, E. E., Matsumoto, T., Exley, M., Schleipman, R. A., Gilckman, J., Bailey, D. T., Corazza, N., Colgan, S. P., Onderdonk, A. B. and Blumberg, R. S., CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 2002. 8: 588-593.
30. Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C.-R., Koezuka, Y. and Kronenberg, M., Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 2000. 192: 741-754.
31. Kemper, C. A. and Deresinski, S. C., The immunology of pneumococcal pneumonia. In Chmel, H., Bendinelli, M. and Friedman, H. (Eds.) Pulmonary infections and immunity. Plenum Press, New York 1994, pp 29-49.
32. Driscoll, K. E., Hassenbein, D. G., Howard, B. W., Isfort, R. J., Cody, D., Tindal, M. H., Suchanek, M. and Carter, J. M., Cloning, expression, and functional characterization of rat MIP-2: a neutrophil chemoattractant and epithelial cell mitogen. J. Leukoc. Biol. 1995. 58: 359-364.
33. Rossi, D. and Zlotonik, A., The biology of chemokines and their receptors. Annu. Rev. Immunol. 2000. 18: 217-242.
34. Mackay, F., Loetscher, H., Stueber, D., Gehr, G. and Lesslauer, W., Tumor necrosis factor-α (TNF-α)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J. Exp. Med. 1993. 177: 1277-1286.
35. Collins, T., Read, M. A., Neish, A. S., Whitley, M. Z., Thanos, D. and Maniatis, T., Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J. 1995. 9: 899-909.
36. Feldmesser, M., Tucker, S. and Casadevall, A., Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol. 2001. 9: 273-278.
37. Maghazachi, A. A., Skalhegg, B. S., Rolstad, B. and Al-Aoukaty, A., Interferon-inducible protein-10 and lymphotactin induce the chemotaxis and mobilization of intracellular calcium in natural killer cells through pertussis toxin-sensitive and -insensitive heterotrimeric G-proteins. FASEB J. 1997. 11: 765-774.
38. Taub, D. D., Sayers, T. J., Carter, C. R. and Ortaldo, J. R., Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 1995.155: 3877-3888.
39. Allavena, P., Bianchi, G., Zhou, D., van Damme, J., Jilek, P., Sozzani, S. and Mantovani, A., Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur. J. Immunol. 1994. 24: 3233-3236.
40. Maghazachi, A. A., Al-Aoukaty, A. and Schall, T. J., C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G-proteins. J. Immunol. 1994. 153: 4969-4977.
41. + mobilization, and enzyme release. J. Immunol. 1996. 156: 322-327.
42. Giancarlo, B., Silvano, S., Albert, Z., Mantovani, A. and Allavena, P., Migratory response of human natural killer cells to lymphotactin. Eur. J. Immunol. 1996. 26: 3235-3241.
43. Faunce, D. E., Sonoda, K. and Stein-Streilein, J., MIP-2 recruits NKT cells to the spleen during tolerance induction. J. Immunol. 2001. 166: 313-321.
44. +NKT cell subsets with distinct cytokine-producing capacity. Blood 2002. 100: 11-16.
45. Hostoffer, R. W., Krukovets, I. and Berger, M., Enhancement by tumor necrosis factor-α of Fcα receptor expression and IgA-mediated superoxide generation and killing of Pseudomonas aeruginosa by polymorphonuclear leukocytes. J. Infect. Dis. 1994. 170: 82-87.
46. Ferrante, A., Martin, A. J., Bares, E. J., Goh, D. H., Harvey, D. P., Parsons, D., Rathjen, D. A., Russ, G. and Dayer, J. M., Killing of Staphylococcus aureus by tumor necrosis factor-α-activated neutrophils. The role of serum opsonins, integrin receptors, respiratory burst, and degranulation. I. Immunol. 1993. 151: 4821-4828.
47. Ferrante, A., Tumor necrosis factor α potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release. Infect. Immun. 1989. 57:2115-2122.
48. Bendelac, A., Hunziker, R. D. and Lantz, O., Increased interleukin 4 and immunoglabulin E production in transgenic mice overexpressing NK1 T cells. J. Exp. Med. 1996. 184: 1285-1293.
49. Singh, N., Hong, S., Scherer, D. C., Serizawa, I., Burdin, N., Kronenberg, M., Koezuka, Y. and van Kaer, L., Activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol. 1999. 163: 2373-2377.
50. Carnaud, C., Lee, D., Donnars, O., Park, S.-H., Beavis, A., Koezuka, Y. and Bendelac, A., Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 1999. 163: 4647-4650.
51. Cui, J., Watanabe, N., Kawano, T., Yamashita, M., Kamata, T., Shimizu, C., Kimura, M., Shimizu, E., Oike, J., Koseki, H., Tanaka, Y., Taniguchi, M. and Nakayama, T., Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer cells. J. Exp. Med. 1999. 190: 783-792.
52. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Sato, H., Kondo, E., Harada, M., Koseki, H., Nakayama, T., Tanaka, Y. and Taniguchi, M., Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proc. Natl. Acad. Sci. USA 1998. 95: 5690-5693.
53. Lu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R., Gerard, C. and Rollins, B. J., Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 1998. 187: 601-608.
54. Kawakami, K., Kohno, S., Morikawa, N., Kadota, J., Saito, A. and Hara, K., Activation of macrophages and expansion of specific T lymphocytes in the lungs of mice intratracheally inoculated with Cryptococcus neoformans. Clin. Exp. Immunol. 1994. 96: 230-237.
55. Gonzalez-Aseguinolaza, G., de Oliveira, C., Tomsaka, M., Hong, S., Bruna-Romero, O., Nakayama, T., Taniguchi, M., Bendelac, A., van Kaer, L., Koezuka, Y. and Tsuji, M., α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA